Danaher Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Danaher Corp. (DHR) shares rose 3.01% to $209.36 on Tuesday, marking its second consecutive day of gains despite a broader market decline. However, the stock underperformed relative to competitors like Thermo Fisher Scientific, which gained 4.61%. Danaher remains 13.77% below its 52-week high. Trading volume was lower than the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Danaher Corp. (DHR) rallied 3.01% to $209.36 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.45% to 7,585.73 and Dow Jones Industrial Average falling 0.63% to 52,093.11.

This was the stock's second consecutive day of gains.

Danaher Corp. closed 13.77% below its 52-week high of $242.80, which the company achieved on January 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Thermo Fisher Scientific Inc. (TMO) rose 4.61% to $641.39, Abbott Laboratories (ABT) fell 1.03% to $102.03, and Medtronic PLC (MDT) fell 0.05% to $93.75.

Trading volume (3.5 M) remained 1.1 million below its 50-day average volume of 4.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-15-26 1636ET

Login to unlock648characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.